Interpretation of INTERACT-2 Study in Intracerebral Hemorrhage

This is a great question, and I understand all too well the challenges of examining the stroke literature.

I will do my best to link to some useful citations and threads here that suggest an answer to some of your questions, and hopefully the others with more expertise can elaborate.

As for your question:

Blockquote
While I assume that most of the datamethods community would advocate for the use of an ordinal regression, this seems to be particularly controversial on Twitter.

Aside from the authority Dr. Harrell (our host), who recommends ordinal logistic regression as a widely applicable technique, the following citations also mention it as one of the preferred ways of examining stroke data.

Can We Improve the Statistical Analysis of Stroke Trials? Statistical Reanalysis of Functional Outcomes in Stroke Trials: The Optimising Analysis of Stroke Trials (OAST) Collaboration
https://www.ahajournals.org/doi/10.1161/strokeaha.106.474080

From the abstract:

Blockquote
Conclusions— When analyzing functional outcome from stroke trials, statistical tests which use the original ordered data are more efficient and more likely to yield reliable results. Suitable approaches included ordinal logistic regression, t test, and robust ranks test.

Statistical Analysis of the Primary Outcome in Acute Stroke Trials
https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.111.641456

Blockquote
Common outcome scales in acute stroke trials are ordered categorical or pseudocontinuous in structure but most have been analyzed as binary measures. The use of fixed dichotomous analysis of ordered categorical outcomes after stroke (such as the modified Rankin Scale) is rarely the most statistically efficient approach and usually requires a larger sample size to demonstrate efficacy than other approaches.

We can eliminate the other methods of inference (t-tests, etc.) as the data from these scales is inherently ordinal. For example:

https://www.sciencedirect.com/science/article/abs/pii/S0022103117307746

These ordinal clinical scales require more sophisticated techniques to analyze. The problems Dr. Harrell mentions in the depression literature that uses the Ham-D is also a problem with the neurological outcome literature (as cited in the Missing Medians) article. In this thread, he describes the use of ordinal proportional odds logistic model, along with nonlinear smoothing methods, to extract information that would be missed by other methods.

Using ordinal regression eliminates the meaningless disputes about “cut offs.” Any particular cut off is arbitrary. See the discussion in Chapter 18 of Biostatistics for Biomedical Research (aka BBR (pdf)). That is a gold mine of wisdom regarding applied statistics. Pay particular attention to the discussion on the information loss by dichotomization of continuous variables. Information loss implies a loss of power, and an effective reduction in the sample size.

I forgot to add: Mixed effects ordinal regression is also recommended as a widely applicable technique for the meta-analyses of individual patient data, or aggregate data summaries.

I doubt I would have ever found this technique if I had not learned of the proportional odds model from BBR and Regression Modelling Strategies (RMS) first.

I’d ask the critics of ordinal regression, how they would aggregate the results from studies that use different cut points into a meta-analysis without access to individual patient data.

There is no coherent method to do so. The different cut points lead to heterogeneous data sets, and the best you could do, being extremely charitable, is a vote count, taking for granted that the direction of the outcome was accurately reported.

If we are to do useful, economical, and ethical research for conditions like ICH, there should be no doubt that the proportional odds ordinal logistic model, within a broader, Bayesian decision theoretic framework is the perspective to take. If we place RCTs into a broader, formal decision making context, more informative yet economical experiments can be designed that answer the questions front line clinicians really want answered.

1 Like